Selective serotonin reuptake inhibitors and risk of fracture in elderly persons [4]

Archives of Internal Medicine

Volumn 167, Issue 21, 2007, Pages 2369-

  Kukoyi, Oladipo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; NORADRENALIN; SEROTONIN UPTAKE INHIBITOR;

BONE DENSITY; CLIMACTERIUM; DEPRESSION; DIABETES MELLITUS; ELDERLY CARE; FRACTURE; HEART INFARCTION; HUMAN; LETTER; NONHUMAN; OSSIFICATION; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 36549062867     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.21.2369-a     Document Type: Letter

References (5)

1. Richards JB, Papaioannou A, Adachi JD, et al; Canadian Multicentre Osteoporosis Study Research Group. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007;167(2):188-194.
2. Hubbard R, Tattersfield A, Smith C, West J, Smeeth L, Fletcher A. Use of inhaled corticosteroids and the risk of fracture. Chest. 2006;130(4):1082-1088.
3. Harlow BL, Wise LA, Otto MW, Soares CN, Cohen LS. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause. Arch Gen Psychiatry. 2003;60(1):29-36.
4. Cizza G, Ravn P, Chrousos GP, Gold PW. Depression: a major, unrecognised risk factor for osteoporosis? Trends Endocrinol Metab. 2001;12(5):198-203.
5. Yirmiya R, Goshen I, Bajayo A, et al. Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci U S A. 2006;103(45):16876-16881.